#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myelodysplastic syndrome Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Transferrin decreased Primary myelofibrosis Acute respiratory distress syndrome Von Hippel-Lindau disease Superficial vein thrombosis Soft tissue sarcoma Breast angiosarcoma Usher's syndrome Chorioretinitis Macular telangiectasia Angiosarcoma recurrent Chondrodystrophy Blood iron increased More trials…

    Learn about Rare Diseases

    Hereditary neuropathic amyloidosis – Diagnostics Immunodeficiency congenital – Basic Information Waldenstrom’s macroglobulinaemia recurrent – Basic Information Prader-Willi syndrome – Treatment Hairy cell leukaemia – Trials in Disease X-linked lymphoproliferative syndrome – Diagnostics Atypical teratoid/rhabdoid tumour of CNS Basal cell naevus syndrome – Basic Information Uterine leiomyosarcoma – Life with Disease Leukoencephalopathy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Daratumumab Itraconazole Selumetinib Sodium Hypochlorite IBUZATRELVIR Tabelecleucel Etranacogene Dezaparvovec FLUORIDE Etrasimod Arginine Lutikizumab Famotidine Valsartan Mk-1088 Morf-057 Ammonium Chloride Bp Pp1815 Trastuzumab Pp1493 Clarithromycin Baricitinib More therapies…

    Learn about Your Condition

    Schizophrenia Diabetic foot Coronary artery bypass Congenital myopathy Escherichia infection Pneumonia Peritoneal neoplasm Cystic fibrosis lung Contusion Anxiety disorder Craniotomy Death neonatal Thalassaemia Dyspepsia Myxofibrosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pneumonia bacterial

  • Study of vitamin D3 (cholecalciferol) as additional treatment for elderly patients with pneumonia or sepsis due to infection

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Sepsis
    • Pneumonia
    • Pneumonia bacterial
    Investigated Drugs:
    • Colecalciferol
    Italy
  • Study on Preventing Early Respiratory Infections in Intubated Patients Using Ceftriaxone, a Cough Simulator, and Subglottic Secretion Aspiration

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Ceftriaxone
    Spain
  • Study on the Effectiveness and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam for Adults with Resistant Bacterial Infections

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Cefepime
    • Nacubactam
    • Relebactam
    Croatia Czechia France Greece Latvia Slovakia +1
  • Study on the Effectiveness and Safety of Imipenem, Cilastatin, and XNW4107 for Adults with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia bacterial
    Investigated Drugs:
    • (1R,4S)-4-(5-((S)-2-Iminioimidazolidin-4-Yl)-1,3,4- Oxadiazol-2-Yl)-6-Oxo-5,7- Diazaspiro[Bicyclo[3.2.1]Octane-2,1′-Cyclopropan]-7-Yl Sulfate
    • Relebactam
    • Cilastatin
    France Spain
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!